{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:40:48Z","timestamp":1785516048019,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fayoum University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Postpartum depression (PPD) is categorized by the Disorders-Fifth Edition as depression that begins during pregnancy or within the first month after giving birth. Ketamine and esketamine have shown promising results in the treatment of several depressive disorders, which suggests that they may have a role in the prevention of PPD. This systematic review and meta-analysis aim to update evidence about the efficacy and safety of using ketamine and esketamine to reduce PPD incidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We searched four databases, PubMed, Scopus, Web of Science, and Cochrane, to collect relevant studies. We included studies which investigated the preventive effect of ketamine or esketamine on PPD among women after giving birth through caesarean or vaginal delivery. We extracted PPD occurrence rate, PPD score, pain score and side effects. Finally, a meta-analysis was conducted using RevMan software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-one eligible studies were incorporated in the current systematic review and meta-analysis involving 4,389 pregnant women. Esketamine was the intervention in 14 studies, and ketamine was used in 7 studies. In subgroup analysis, both ketamine and esketamine were significantly effective in reducing the incidence of short-term PPD (ketamine: RR\u2009=\u20090.72, 95% CI [0.56, 0.93], <jats:italic>P<\/jats:italic>\u2009=\u20090.01; esketamine: RR\u2009=\u20090.43, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Esketamine only significantly reduced the incidence of long-term PPD (RR\u2009=\u20090.44, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.00001). Low doses and high doses were effective in reducing the incidence of both short-term (high dose: RR\u2009=\u20090.48, <jats:italic>P<\/jats:italic>\u2009=\u20090.0005; low dose: RR\u2009=\u20090.46, <jats:italic>P<\/jats:italic>\u2009=\u20090.002) and long-term PPD (high dose: RR\u2009=\u20090.54, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001; low dose: RR\u2009=\u20090.61, <jats:italic>P<\/jats:italic>\u2009=\u20090.009). Regarding the risk of side effects, patients in the Ketamine\/esketamine group showed statistically significant higher rates of developing dizziness (<jats:italic>P<\/jats:italic>\u2009=\u20090.0007), blurred vision (<jats:italic>P<\/jats:italic>\u2009=\u20090.02), vomiting (<jats:italic>P<\/jats:italic>\u2009=\u20090.004) and hallucinations (<jats:italic>P<\/jats:italic>\u2009=\u20090,002) than women in the control group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Both ketamine and esketamine are effective in lowering the incidence of short-term PPD. On the other hand, only esketamine is effective in reducing the incidence of long-term PPD. It is recommended to use smaller doses for a more tolerable treatment period since doses less than 0.5\u00a0mg are significantly effective. Temporary side effects such as dizziness, blurred vision, vomiting and hallucinations were reported.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12884-025-07186-y","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:09:16Z","timestamp":1738829356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-058X","authenticated-orcid":false,"given":"Moaz Yasser","family":"Darwish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1874-6674","authenticated-orcid":false,"given":"Abdallah A.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-0262","authenticated-orcid":false,"given":"Yousif Ahmed","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9801-8775","authenticated-orcid":false,"given":"Manar Alaa","family":"Mabrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4563-6585","authenticated-orcid":false,"given":"Aya","family":"Alrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3167-8247","authenticated-orcid":false,"given":"Taha Abd-ElSalam","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-6465","authenticated-orcid":false,"given":"Nada K.","family":"Abdelsattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3033-117X","authenticated-orcid":false,"given":"Fatma Mohammed","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-9161","authenticated-orcid":false,"given":"Mohamed","family":"Abd-ElGawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"7186_CR1","unstructured":"Corr\u00eaa MS, Feliciano KV, Pedrosa EN, Souza AI. Postpartum follow-up of women\u2019s health. (1678\u20134464 (Electronic))."},{"key":"7186_CR2","unstructured":"Mgonja S, Fau - Schoening A, Schoening A. Postpartum Depression Screening at Well-Child appointments: a Quality Improvement Project. (1532-656X (Electronic))."},{"key":"7186_CR3","unstructured":"Ukatu N, Clare CA, Brulja M. Postpartum Depression Screening Tools: A Review. (1545\u20137206 (Electronic))."},{"key":"7186_CR4","unstructured":"Rogathi JJ, Manongi R, Mushi D, Rasch V, Sigalla GN, Gammeltoft T et al. Postpartum depression among women who have experienced intimate partner violence: a prospective cohort study at Moshi. Tanzania. (1573\u20132517 (Electronic))."},{"key":"7186_CR5","unstructured":"Kroska EB, Stowe ZN. Postpartum Depression: Identification and Treatment in the Clinic Setting. (1558\u2009\u2013\u20090474 (Electronic))."},{"key":"7186_CR6","unstructured":"Stewart DE, Vigod SN. Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics. (1545-326X (Electronic))."},{"key":"7186_CR7","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.2147\/NDT.S117146","volume":"12","author":"Y Han","year":"2016","unstructured":"Han Y, Chen J, Zou D, Zheng P, Li Q, Wang H, et al. Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies. Neuropsychiatr Dis Treat. 2016;12:2859\u201367.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"7186_CR8","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1017\/S0033291716000064","volume":"46","author":"T Kishimoto","year":"2016","unstructured":"Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, et al. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med. 2016;46(7):1459\u201372.","journal-title":"Psychol Med"},{"key":"7186_CR9","unstructured":"Canuso CM, Singh JB, Fedgchin M, Alphs L, Lane R, Lim P et al. Efficacy and Safety of Intranasal Esketamine for the Rapid reduction of symptoms of Depression and Suicidality in patients at imminent risk for suicide: results of a Double-Blind, randomized, placebo-controlled study. (1535\u20137228 (Electronic))."},{"key":"7186_CR10","doi-asserted-by":"crossref","unstructured":"Alshammari TK. The Ketamine Antidepressant Story: New Insights. LID \u2013\u200910.3390\/molecules25235777 [doi] LID \u2013\u20095777. (1420\u20133049 (Electronic)).","DOI":"10.3390\/molecules25235777"},{"key":"7186_CR11","unstructured":"Shinohara R, Aghajanian GK, Abdallah CG. Neurobiology of the Rapid-Acting Antidepressant effects of ketamine: Impact and opportunities. (1873\u20132402 (Electronic))."},{"issue":"10","key":"7186_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013;170(10):1134\u201342.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"7186_CR13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"7186_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.coph.2014.11.005","volume":"20","author":"ET Kavalali","year":"2015","unstructured":"Kavalali ET, Monteggia LM. How does ketamine elicit a rapid antidepressant response? Curr Opin Pharmacol. 2015;20:35\u20139.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"7186_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.25122\/jml-2020-0116","volume":"14","author":"M Alipoor","year":"2021","unstructured":"Alipoor M, Loripoor M, Kazemi M, Farahbakhsh F, Sarkoohi A. The effect of ketamine on preventing postpartum depression. J Med Life. 2021;14(1):87\u201392.","journal-title":"J Med Life"},{"issue":"9","key":"7186_CR16","doi-asserted-by":"publisher","first-page":"e01715","DOI":"10.1002\/brb3.1715","volume":"10","author":"J Yao","year":"2020","unstructured":"Yao J, Song T, Zhang Y, Guo N, Zhao P. Intraoperative ketamine for reduction in postpartum depressive symptoms after cesarean delivery: a double-blind, randomized clinical trial. Brain Behav. 2020;10(9):e01715.","journal-title":"Brain Behav"},{"issue":"7","key":"7186_CR17","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.","journal-title":"PLoS Med"},{"key":"7186_CR18","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"7186_CR19","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson j, Welch V, Losos M et al. The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. \u115f. 2000;&#4447."},{"key":"7186_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2288-9-80","volume":"9","author":"BC Wallace","year":"2009","unstructured":"Wallace BC, Schmid CH, Lau J, Trikalinos TA. Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol. 2009;9:80.","journal-title":"BMC Med Res Methodol"},{"key":"7186_CR21","doi-asserted-by":"crossref","unstructured":"Deeks JJ, Higgins JP, Altman DG. interventions CSMGJChfsro. Analysing data and undertaking meta-analyses. 2019:241\u2009\u2013\u200984.","DOI":"10.1002\/9781119536604.ch10"},{"key":"7186_CR22","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.2147\/JPR.S427702","volume":"16","author":"Y Guo","year":"2023","unstructured":"Guo Y, Ding X, Wang S, Wang F, Zheng Z, Zou L. Analgesic effect of esketamine combined with tramadol for patient-controlled intravenous analgesia after cesarean section: a randomized controlled trial. J Pain Res. 2023;16:3519\u201328.","journal-title":"J Pain Res"},{"issue":"1","key":"7186_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12871-022-01588-7","volume":"22","author":"Y Han","year":"2022","unstructured":"Han Y, Li P, Miao M, Tao Y, Kang X, Zhang J. S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial. BMC Anesthesiol. 2022;22(1):49.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"7186_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12871-024-02436-6","volume":"24","author":"S Li","year":"2024","unstructured":"Li S, Zhuo Z, Li R, Guo K. Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial. BMC Anesthesiol. 2024;24(1):52.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"7186_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40360-023-00705-7","volume":"24","author":"B Ling","year":"2023","unstructured":"Ling B, Zhu Y, Yan Z, Chen H, Xu H, Wang Q, et al. Effect of single intravenous injection of esketamine on postpartum depression after labor analgesia and potential mechanisms: a randomized, double-blinded controlled trial. BMC Pharmacol Toxicol. 2023;24(1):66.","journal-title":"BMC Pharmacol Toxicol"},{"key":"7186_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jad.2023.07.103","volume":"339","author":"QR Liu","year":"2023","unstructured":"Liu QR, Zong QK, Ding LL, Dai HY, Sun Y, Dong YY, et al. Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: a randomized controlled trial. J Affect Disord. 2023;339:815\u201322.","journal-title":"J Affect Disord"},{"key":"7186_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.psychres.2019.03.026","volume":"279","author":"JH Ma","year":"2019","unstructured":"Ma JH, Wang SY, Yu HY, Li DY, Luo SC, Zheng SS, et al. Prophylactic use of ketamine reduces postpartum depression in Chinese women undergoing cesarean section(\u2730). Psychiatry Res. 2019;279:252\u20138.","journal-title":"Psychiatry Res"},{"issue":"1","key":"7186_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12884-022-05118-8","volume":"22","author":"DT Monks","year":"2022","unstructured":"Monks DT, Palanisamy A, Jaffer D, Singh PM, Carter E, Lenze S. A randomized feasibility pilot-study of intravenous and subcutaneous administration of ketamine to prevent postpartum depression after planned cesarean delivery under neuraxial anesthesia. BMC Pregnancy Childbirth. 2022;22(1):786.","journal-title":"BMC Pregnancy Childbirth"},{"key":"7186_CR29","doi-asserted-by":"publisher","first-page":"1038379","DOI":"10.3389\/fpsyt.2022.1038379","volume":"13","author":"J Shen","year":"2022","unstructured":"Shen J, Song C, Lu X, Wen Y, Song S, Yu J, et al. The effect of low-dose esketamine on pain and post-partum depression after cesarean section: a prospective, randomized, double-blind clinical trial. Front Psychiatry. 2023;13:1038379.","journal-title":"Front Psychiatry"},{"key":"7186_CR30","doi-asserted-by":"publisher","first-page":"1050232","DOI":"10.3389\/fsurg.2022.1050232","volume":"9","author":"S Wang","year":"2022","unstructured":"Wang S, Deng CM, Zeng Y, Ma JH, Qu Y, Wang DX. Single low-dose ketamine infusion for women with prenatal depressive symptoms undergoing cesarean delivery: a pilot randomized trial. Front Surg. 2022;9:1050232.","journal-title":"Front Surg"},{"issue":"9","key":"7186_CR31","doi-asserted-by":"publisher","first-page":"e33086","DOI":"10.1097\/MD.0000000000033086","volume":"102","author":"W Wang","year":"2023","unstructured":"Wang W, Ling B, Chen Q, Xu H, Lv J, Yu W. Effect of pre-administration of esketamine intraoperatively on postpartum depression after cesarean section: a randomized, double-blinded controlled trial. Medicine (Baltimore). 2023;102(9):e33086.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"7186_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12871-023-02377-6","volume":"24","author":"W Wang","year":"2024","unstructured":"Wang W, Ling B, Zhao H, He J, Xu H, Lv J, et al. Effect of esketamine on postpartum depression after labor analgesia and potential mechanisms: a randomized, double-blinded controlled trial. BMC Anesthesiol. 2024;24(1):4.","journal-title":"BMC Anesthesiol"},{"issue":"47","key":"7186_CR33","doi-asserted-by":"publisher","first-page":"e32010","DOI":"10.1097\/MD.0000000000032010","volume":"101","author":"W Wang","year":"2022","unstructured":"Wang W, Xu H, Ling B, Chen Q, Lv J, Yu W. Effects of esketamine on analgesia and postpartum depression after cesarean section: a randomized, double-blinded controlled trial. Medicine (Baltimore). 2022;101(47):e32010.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"7186_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12871-023-02398-1","volume":"24","author":"S Xu","year":"2024","unstructured":"Xu S, Yang J, Li J, Zhang M, Sun J, Liu Q, et al. Esketamine pretreatment during cesarean section reduced the incidence of postpartum depression: a randomized controlled trail. BMC Anesthesiol. 2024;24(1):20.","journal-title":"BMC Anesthesiol"},{"issue":"5","key":"7186_CR35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00404-017-4334-8","volume":"295","author":"Y Xu","year":"2017","unstructured":"Xu Y, Li Y, Huang X, Chen D, She B, Ma D. Single bolus low-dose of ketamine does not prevent postpartum depression: a randomized, double-blind, placebo-controlled, prospective clinical trial. Arch Gynecol Obstet. 2017;295(5):1167\u201374.","journal-title":"Arch Gynecol Obstet"},{"key":"7186_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jad.2023.07.007","volume":"339","author":"SQ Yang","year":"2023","unstructured":"Yang SQ, Zhou YY, Yang ST, Mao XY, Chen L, Bai ZH, et al. Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: a randomized, double-blind, controlled clinical study. J Affect Disord. 2023;339:333\u201341.","journal-title":"J Affect Disord"},{"issue":"1","key":"7186_CR37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12884-021-04229-y","volume":"21","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wang J, An XH, Chao YC, Bian Y, Xu Z, et al. Optimum dose of spinal ropivacaine with or without single intravenous bolus of S-ketamine during elective cesarean delivery: a randomized, double-blind, sequential dose-finding study. BMC Pregnancy Childbirth. 2021;21(1):746.","journal-title":"BMC Pregnancy Childbirth"},{"key":"7186_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jad.2023.02.028","volume":"328","author":"H Liu","year":"2023","unstructured":"Liu H, Dai A, Zhou Z, Xu X, Gao K, Li Q, et al. An optimization for postpartum depression risk assessment and preventive intervention strategy based machine learning approaches. J Affect Disord. 2023;328:163\u201374.","journal-title":"J Affect Disord"},{"issue":"7","key":"7186_CR39","first-page":"424","volume":"29","author":"F Lou","year":"2023","unstructured":"Lou F, Wang C, Dong X, Jin L, Chen H, Lu Y, et al. Analysis of the analgesic effect, emotion, and safety of esketamine in cesarean section analgesia for puerperae. Altern Ther Health Med. 2023;29(7):424\u20138.","journal-title":"Altern Ther Health Med"},{"issue":"1","key":"7186_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21037\/apm-21-3343","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Q, Dai X, Xiao G, Luo H. Effect of low-dose esketamine on pain control and postpartum depression after cesarean section: a retrospective cohort study. Annals Palliat Med. 2022;11(1):45\u201357.","journal-title":"Annals Palliat Med"},{"issue":"9","key":"7186_CR41","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","volume":"76","author":"EJ Daly","year":"2019","unstructured":"Daly EJ, Trivedi MH, Janik A, Li H, Zhang Y, Li X, et al. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry. 2019;76(9):893\u2013903.","journal-title":"JAMA Psychiatry"},{"key":"7186_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpsychires.2021.02.058","volume":"137","author":"JD Di Vincenzo","year":"2021","unstructured":"Di Vincenzo JD, Siegel A, Lipsitz O, Ho R, Teopiz KM, Ng J, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: a systematic review. J Psychiatr Res. 2021;137:232\u201341.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"7186_CR43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","volume":"176","author":"V Popova","year":"2019","unstructured":"Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428\u201338.","journal-title":"Am J Psychiatry"},{"key":"7186_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jad.2020.01.002","volume":"265","author":"W Zheng","year":"2020","unstructured":"Zheng W, Cai DB, Xiang YQ, Zheng W, Jiang WL, Sim K, et al. Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies. J Affect Disord. 2020;265:63\u201370.","journal-title":"J Affect Disord"},{"issue":"4","key":"7186_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351\u20134.","journal-title":"Biol Psychiatry"},{"key":"7186_CR46","doi-asserted-by":"publisher","first-page":"204209862093789","DOI":"10.1177\/2042098620937899","volume":"11","author":"MS Salahudeen","year":"2020","unstructured":"Salahudeen MS, Wright CM, Peterson GM. Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review. Ther Adv drug Saf. 2020;11:2042098620937899.","journal-title":"Ther Adv drug Saf"},{"key":"7186_CR47","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jad.2024.01.202","volume":"351","author":"S Li","year":"2024","unstructured":"Li S, Zhou W, Li P, Lin R. Effects of ketamine and esketamine on preventing postpartum depression after cesarean delivery: A meta-analysis. J Affect Disord. 2024;351:720\u20138. https:\/\/doi.org\/10.1016\/j.jad.2024.01.202.","journal-title":"J Affect Disord"},{"issue":"4","key":"7186_CR48","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018;23(4):801\u201311.","journal-title":"Mol Psychiatry"},{"key":"7186_CR49","doi-asserted-by":"publisher","first-page":"114396","DOI":"10.1016\/j.psychres.2022.114396","volume":"310","author":"Q Li","year":"2022","unstructured":"Li Q, Wang S, Mei X. A single intravenous administration of a sub-anesthetic ketamine dose during the perioperative period of cesarean section for preventing postpartum depression: a meta-analysis. Psychiatry Res. 2022;310:114396.","journal-title":"Psychiatry Res"},{"issue":"3","key":"7186_CR50","doi-asserted-by":"publisher","first-page":"101241","DOI":"10.1016\/j.ajogmf.2023.101241","volume":"6","author":"S Ma","year":"2024","unstructured":"Ma S, Dou Y, Wang W, Wei A, Lan M, Liu J, et al. Association between esketamine interventions and postpartum depression and analgesia following cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2024;6(3):101241.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"1","key":"7186_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","volume":"5","author":"B Short","year":"2018","unstructured":"Short B, Fong J, Galvez V, Shelker W, Loo CK. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018;5(1):65\u201378.","journal-title":"Lancet Psychiatry"},{"key":"7186_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/jehp.jehp_97_18","volume":"8","author":"L Kaya","year":"2019","unstructured":"Kaya L, \u00c7i\u011fdem Z. The relationship between mode of delivery and postpartum depression. J Educ Health Promot. 2019;8:5.","journal-title":"J Educ Health Promot"},{"key":"7186_CR53","doi-asserted-by":"publisher","first-page":"874","DOI":"10.4103\/ATMPH.ATMPH_236_17","volume":"10","author":"SB Sarah","year":"2017","unstructured":"Sarah SB, Forozan SP, Leila D. The relationship between model of delivery and postpartum depression. Annals Trop Med Public Health. 2017;10:874\u20137.","journal-title":"Annals Trop Med Public Health"},{"issue":"6","key":"7186_CR54","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/0004867420954284","volume":"55","author":"L Sun","year":"2021","unstructured":"Sun L, Wang S, Li XQ. Association between mode of delivery and postpartum depression: a systematic review and network meta-analysis. Aust N Z J Psychiatry. 2021;55(6):588\u2013601.","journal-title":"Aust N Z J Psychiatry"},{"key":"7186_CR55","doi-asserted-by":"publisher","first-page":"616759","DOI":"10.5402\/2012\/616759","volume":"2012","author":"A Goker","year":"2012","unstructured":"Goker A, Yanikkerem E, Demet MM, Dikayak S, Yildirim Y, Koyuncu FM. Postpartum depression: is mode of delivery a risk factor? ISRN Obstet Gynecol. 2012;2012:616759.","journal-title":"ISRN Obstet Gynecol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07186-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07186-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07186-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:37:29Z","timestamp":1738831049000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07186-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7186"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07186-y","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}